Ming Zheng

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations

Medicine, Oncology, Pharmacotherapy +17

Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

Lee S. Rosen, David Gordon, N. Simon Tchekmedyian et al. · Cancer · 2004 · 716 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors

J. E. Brown, Richard J. Cook, Pierre Major et al. · JNCI Journal of the National Cancer Institute · 2005 · 564 citations · Full text

Medicine, Biostatistics, Oncology +16

Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid

Robert E. Coleman, Pierre Major, Allan Lipton et al. · Journal of Clinical Oncology · 2005 · 531 citations · Full text

Medicine, Oncology, Bone Metabolism +16

Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer

Matthew R. Smith, Fairooz F. Kabbinavar, Fred Saad et al. · Journal of Clinical Oncology · 2005 · 497 citations · Full text

Medicine, Oncology, Urology +17